FDA Approves Combination Of Ezetimibe And Atorvastatin

The FDA has approved a new combination drug from Merck for lowering cholesterol. The drug, which will carry the brand name of Liptruzet, is a combination of two previously approved cholesterol-lowering drugs, ezetimibe and atorvastatin.

Source: Forbes.com Healthcare News - May 3, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news